von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support.
Center for Advanced Heart Failure, University of Texas at Houston, Houston, Texas.
Angelo
A
Nascimbene
BloodWorks Northwest Research Institute, Seattle, Washington.
Tristan
T
Hilton
BloodWorks Northwest Research Institute, Seattle, Washington; Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Barbara A
BA
Konkle
J.W. Cox Laboratory for Biomedical Engineering, Rice University, Houston, Texas.
Joel L
JL
Moake
Texas Heart Institute, Baylor College of Medicine, Houston, Texas.
O H
OH
Frazier
BloodWorks Northwest Research Institute, Seattle, Washington; Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Jing-Fei
JF
Dong
D000071120:ADAMTS13 Protein / Q000097:blood*; D000328:Adult; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000601:surgery; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D059748:Proteolysis; D012307:Risk Factors; D014841:von Willebrand Factor / Q000378:metabolism*
D014841:von Willebrand Factor; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human